延长时间窗内卒中取栓治疗时间与结局的荟萃分析
该研究汇总6项随机试验的个体患者数据,评估延长时间窗(6-24小时)内血管内取栓治疗时间与结局的关联。共纳入505例患者,其中266例接受EVT。结果显示,EVT患者中发病至随机化时间与残疾或功能独立无关,而对照组患者随着时间延长结局更差,导致后期治疗获益更大;但随机化至再灌注时间延长与更差结局相关。
要点
- 在延长时间窗内,经高级影像筛选的患者中EVT的获益持续存在。
- 发病至随机化时间延长在EVT患者中未显著影响结局,但在对照组中结局更差。
- 院内延迟(随机化至再灌注)延长与更差残疾和功能独立相关。
核心结论
- 在延长时间窗(6-24小时)内,采用高级影像标准筛选的患者中,EVT的获益持续存在。
- 发病至就诊时间延长时治疗效应的表观增加反映了生理性筛选的有效性,而非真正的时间不敏感。
- 院内延迟(随机化至再灌注)延长与更差结局强烈相关,强调「时间就是大脑」。
研究设计与样本
- 汇总6项随机试验的个体患者水平数据,纳入在延长时间窗内入组的患者。
- 共505例参与者,中位年龄70岁,基线NIHSS 16,女性占51.3%,86.5%采用高级影像筛选。
- 266例(52.7%)接受EVT,239例(47.3%)仅药物治疗。
主要发现
- EVT患者中,发病至随机化时间每延长60分钟,残疾调整OR为1.02(95%CI 0.96-1.08;p=0.53),功能独立调整OR为1.06(95%CI 0.95-1.17;p=0.28)。
- 对照组患者中,发病至随机化时间每延长60分钟,残疾调整OR为0.93(95%CI 0.87-1.00;p=0.041),功能独立调整OR为0.84(95%CI 0.73-0.97;p=0.019)。
- 治疗与时间的交互作用p值分别为0.033(残疾)和0.003(功能独立),显示后期治疗获益更大。
- EVT患者中,发病至穿刺或发病至再灌注时间与结局无显著关联。
- 随机化至再灌注时间延长与更差残疾(调整OR 0.58;95%CI 0.37-0.91;p=0.018)和更低功能独立(调整OR 0.51;95%CI 0.28-0.96;p=0.038)相关。
关键数值与推荐
- 延长时间窗定义为发病后6-24小时。
- 主要结局为90天残疾程度(mRS 0-6),次要结局包括功能独立(mRS 0-2)、死亡和症状性颅内出血。
- EVT患者中发病至随机化时间与结局无显著关联,而对照组中时间延长与更差结局相关。
临床怎么用
- 对于延长时间窗(6-24小时)内的大血管闭塞卒中患者,应依据高级影像标准筛选后积极考虑EVT。
- 不应因发病至就诊时间较长而延误EVT,但需尽可能缩短院内延迟以改善结局。
- 生理性筛选可重置治疗时钟,但院前延迟仍可能有害,应优化急救流程。
局限性
- 研究基于高度筛选的人群(86.5%采用高级影像),结果可能不适用于未筛选患者。
- 为个体患者数据荟萃分析,可能存在未测量混杂因素。
- 样本量有限(505例),亚组分析效能不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Time to endovascular thrombectomy (EVT) is a critical determinant of outcomes for large vessel occlusion (LVO) strokes presenting within 6 hours of onset. Its impact in the extended (6-24-hour) window remains uncertain. We aimed to evaluate the association between treatment times and outcomes in this window. METHODS: Individual patient-level data from 6 randomized trials enrolling patients in the extended window were pooled. The primary outcome was degree of disability at 90 days (modified Rankin Scale [mRS] 0-6). Secondary outcomes included functional independence (mRS 0-2), mortality, and symptomatic intracranial hemorrhage. RESULTS: Among 505 participants (median age 70 years; baseline NIH Stroke Scale 16; 51.3% female; advanced imaging selection 86.5%), 266 (52.7%) received EVT and 239 (47.3%) medical therapy alone. In EVT-treated patients, longer onset-to-randomization times were not associated with differences in disability (adjusted odds ratio [aOR] per 60 minutes 1.02; 95% CI 0.96-1.08; p = 0.53) or functional independence (aOR 1.06; 95% CI 0.95-1.17; p = 0.28). Conversely, control patients exhibited worse outcomes with increasing onset-to-randomization times (aOR for disability 0.93; 95% CI 0.87-1.00; p = 0.041; functional independence 0.84; 95% CI 0.73-0.97; p = 0.019), resulting in greater treatment benefit at later times (p-interaction = 0.033 and 0.003, respectively). No association was observed between onset-to-puncture or onset-to-reperfusion and outcomes in EVT patients. However, longer randomization-to-reperfusion times correlated with worse disability (aOR 0.58; 95% CI 0.37-0.91; p = 0.018) and lower functional independence (aOR 0.51; 95% CI 0.28-0.96; p = 0.038). DISCUSSION: This study demonstrates that the benefit of EVT is consistently preserved across the extended (6-24-hour) time window when patients are selected using advanced imaging criteria. In this highly selected population, enriched with slow progressors, the apparent increase in treatment effect with longer onset-to-presentation times reflects the validity of physiologic selection rather than true time insensitivity. However, this observation should not diminish the critical importance of time: imaging-based selection effectively resets the treatment clock, masking the harmful impact of prehospital delays. Notably, longer in-hospital delays were strongly associated with worse outcomes, reinforcing that "time is brain," even in extended-window cohorts.
引用
- Nogueira RG, Jovin TG, Lansberg MG, et al. Time to Treatment in Stroke Thrombectomy and Outcomes in the Extended Time Window: A Meta-Analysis. Neurology. 2026. PMID: 42475646. doi:10.1212/WNL.0000000000218113
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。